KOREA PHARM 2015 hostED BUYER Programk-jit.com/.../KOREA-PHARM-2015_Exhibitor-List_20150224.pdfresearch and development and made continuous efforts to produce high-quality products

KOREA PHARM 2015 HOSTED BUYER PROGRAM

21 Tue.-24 Fri. APRIL, KINTEX 1, KOREA

No. 会社名 Business

Focus 主な商品 Homepage √

1 AHN-GOOK PHARMACEUTICAL COMPANY LTD.

改良新薬

Main Products 1. Letopra tablet (S-pantoprazole) 2. Olmos-F tablet (Olmesartan cilexetil) 3. Synatura syrup (Ivy leaf extract + coptidis rhizoma) 4. Anycough capsule (Theobromine) 5. Acefenac CR tablet (Aceclofenac)

R&D Pipeline 1. SAV301 / S-project / Antihypertension 2. AG SCT101 / S-project / Antihypertension 3. Rupatadine / NCE / Allergic rhinitis 4. AG AK903 / Natural Product / Periodontal disease 5. AG NRF / Natural Product / Nephritis Remedies

www.ahn-gook.com □

2 BEXPHARM HEALTH CARE

Pharmaceuticals - Importer /

Distributor, OEM

Medical Device : Manufacture,

Importer / Distributor

Logistics :

Fresenius Medical Care Korea Partnership

Company Introduction BexpharmKorea Ltd. seeks to maintain client-centered management with respect for human beings. Ever since the foundation of the company in 2001, we have been offering high quality customer satisfaction and convenience to keep our continued and close relationship with the customers. New medicines are being introduced but there is lack of supply for the demand. We continue to excel in providing appropriate care for the patients without cure or appropriate cure available. We BexpharmKorea will provide top quality products with excellent service to provide value that you deserve and we are reaching for the top with the creativity, providing finest customer satisfaction, and we're will be a beautiful company to you always Main Products

• Exclusive Products in Korea

Trade name Composition Provider

Lactitol powder

Laxative, Hepatic encephalopathy

yuhan Pharmaceuticals

Portalac syrup

Prebiotics, For the Treatment of Consitpation

DuPont Danisco. U.S.A Inc

Menoferil

Selective Estrogen Receptor

Modulator(SERM) Dawon Pharmaceuticals

Hepasphere Microspheres

Hepatic TACE MeritMedical.U.S.A

Embosphere Microspheres

Myoma of the uterus MeritMedical.U.S.A

Epiceram Skin barrier repair therapy

PuraCap Pharmaceutical U.S.A

Flaminal

Enzyme alginogel protects the wound

Flen Pharma , Belgium

Physiodose

Physiological saline solution

Gilbert, France

RepHresh Vaginosis Lil Drug product Inc.

Replens Vaginal Dryness Lil Drug product Inc

• Others : Distribution of some Imported & Local Products

www.bexpharm.com □

3 BORYUNG PHARMACEUTICAL CO., LTD.

CVS, CNS, Oncology

Company Introduction Boryung Pharmaceutical Co., Ltd founded in 1963, has put a strong presence in Korean market as one of TOP leading pharmaceutical companies. Boryung has invested continually on research and development and made continuous efforts to produce high-quality products in the specialty areas such as cardiovascular, antineoplastic and antibiotics drugs. Boryung has developed Kanarb(Fimasartan), an innovative anti-hypertensive drug that has been approved by the KFDA as the 15th new drug, also it is 8th new ARB drug in the world. It has been licensed-out in 16 countries including Mexico, Brazil, Russia & China worth the amount of $200 million and we are continuing to expand the global network to reference countries such as USA, EU, Japan and the pharmerging markets (ASEAN, Middle East, and Africa etc.)

Main Products 1. Kanarb (Innovative Anti-Hypertensive Drug) 2. Buspar (Buspirone) 3. Taxol (Paclitaxel) 4. Astrix (Aspirin) 5. Megace 6. Meiact (Cefditoren) 7. Gelfos M

www.boryung.co.kr □

4 BUMINSA Cleanroom

subsidiary materials and consumables

Cleanroom subsidiary materials and consumables www.buminsa.com □

5 CHARLES RIVER LABORATORIES KOREA

CRO Company Introduction Charles River helps our global partners with high-quality research models and services; discovery, preclinical and clinical support; and

www.criver.co.kr □

INTERESTING COMPANY (ご興味がある企業を選んでください。)



endotoxin products and services, microbial identification services. Our portfolio spans the entire research and drug development process, with flexible approaches for any program size. Charles River Laboratories Korea has been providing Discovery/Preclinical services, endotoxin products and technical support service. In addition, Charles River Korea has been also providing Microbial Identification services compliant to cGMP for Asia Pacific clients since September 2013.

Main Products 1. Rapid Endotoxin Testing Charles River‟s rapid endotoxin testing systems, the Endosafe®-PTS™ and Endosafe®-MCS™, utilize FDA-licensed test cartridges to provide results on-site in just 15 minutes. Endosafe® Nexus™ which is the first fully automated robotic system designed specifically for endotoxin testing in the central QC lab, it is ideal for high-volume water testing or samples that require dilutions.

2. Microbial Identification Services> AccuGENX-ID® is our identification service utilized DNA Sequencing of the 16S ribosomal RNA(rRNA) gene in bacteria and

ITS2 rRNA region in fungi, recognized as the most accurate and reproducible method for identifying unknown organisms. And AccuPRO-ID® is a first-in-industry polyphasic approach to microbial identification utilizing proteotypic MALDI-TOF technology.

6 CHONG KUN DANG PHARMACEUTICAL CORP.

Cardiovascular and metabolic disease,

Oncology, Immunology

Main Products 1. Lipilou(Atorvastatin) is our top selling product with sales of about $33m. This is the highest among all (generic) products of atorvastatin except Lipitor by Pfizer. 2. Tacrobell(Tacrolimus) has enabled to smoothly absorb tacrolimus in GI tract by improving the bioavailability using our novel solid dispersion technology. 3. Cipol-N(Cyclosporine Microemulsion) has been produced by our own technology, awarded for „KT mark‟ meaning the excellent Korean technology. 4. Telminuvo(Telmisartan and S-Amlodipine) effectively reduces blood pressure in hypertensive patients. It has become one of our major products since its launch in April 2013. 5. Pregrel(Clopidogrel Resinate), a new salt form of clopidogrel, has shown to be more stable and highly safer than Plavix that is susceptible to degradation. R&D Pipeline 1. CKD-732 is the first-in-class compound targeting methionine aminopeptidase-2. It reduces the production of fatty acid and helps to convert stored fats into useful energy. Phase IIa for severe obesity was completed by Zafgen, our licensed partner in the US. 2. CKD-516 disrupts the formation of blood vessel around the tumor by inhibiting tubulin polymerization. It is applicable to a variety of solid tumors. Phase I is ongoing with the National OncoVenture. 3. CKD-519, as a novel therapy for the dyslipidemia, remarkably raises HDL cholesterol and improves lipid profile through inhibiting CETP. Phase I will be initiated in 2014. 4. CKD-841 is a novel sustained release formulation of Leuprolide using our proprietary technology, the injectable Liquid-Crystal system, which can be applied to a wide range of drugs including peptide and proteins, superior to well-known PLGA microparticle injections. Phase I will be initiated in 2014. 5. DC-002 is a novel HDAC6-selective inhibitor in preclinical stage for treating various autoimmune diseases. It is expected to show a superior safety and efficacy profile to other competitors. New Active Substances 1. Camtobell, our first new chemical drug, has an effect on patients with ovarian and small cell lung cancer through the inhibition of topoisomerase I. Sales of Camtobell were about $2m. 2. Duvie, a selective PPAR-gamma agonist, is a novel anti type2 diabetic therapeutics commercialized in Korea in February 2014. Duvie is safe from cardiovascular risks by improving lipid profile.

www.ckdpharm.com □

7 CHUNGBUK FREE ECONOMIC ZONE AUTHORITY

Introduction The BioValley in Osong will be developed into a mecca of next-generation, new biotechnology drug industries and ICT convergence medical device industries, while Aeropolis around Cheongju International Airport will be an aviation complex incorporating aircraft MRO, passenger transportation, logistics and shopping. Furthermore, Ecopolis in the Chungju region will transform into a biological recreational and automotive electronics industrial park. The CBFEZ will reward your investment with confidence and tangible results, offering the geographical advantage of the center of Korea and Northeast Asia as well as optimal operational environments including quality transportation and logistics infrastructure.

http://cbfez.go.kr □



8 CJ HEALTHCARE CORP.

ETC(CVs, Antibiotics, IV

Solution, Oncology, Endocrinology, Nephrology &

Urology, Gastro Intestinal, Musculo

skeletal, Respiratory,

Others), OTC

Company Introduction Since CJ HealthCare was established in 1984, the company has taken firm leadership in the local pharmaceutical market thanks to its product lineup of ethical (ETC) drugs such as anticancer, circulatory system, diabetes, and kidney disease treatments and over-the-counter (OTC) drugs. We have also acquired Hanil Pharmaceutical in 2004, reinforcing our competitive edges in the pharmaceutical market. CJ HealthCare was designated as an 'Innovative Pharmaceutical Company' by the Ministry of Health and Welfare in 2012. Main Products

• Epokine (Erythropoietin-α)

Epokine®, the Most Reliable Choice for Renal Anemia – Developed 1st in Korea and 3rd in the world Epokine® is safe and effective in treating anemia of hemodialysis patients with end-stage renal

disease (Phase Ⅲ clinical study)

• Leukokine (Filgrastim)

Leukokine® has the same efficacy and safety with those of the control on neutropenia - For the Neutropenia Induced by Chemo therapy in Advanced Cancer Patients - For the Neutropenia Induced by Chemotherapy in Acute Leukemia Patients

• Tapocin® (Teicoplanin)

Tapocin® is the first choice for the treatment of MRSA, MRSE and Enterococcus 1. Excellent antibacterial effects on MRSA, MRSE and Enterococcus 2. Once-daily dosing 3. The Efficacy and Safety proved by clinical trial

• Vancorin® (Vancomycin)

Vancomycin® is the best choice for MRSA & MRSE. - Reliable supplier of vancomycin injection for over 10 years - A proven Efficacy and Safety on Asian people

www.cjp.co.kr □

9 CLPHARM Film-type drugs,

OTC, Health functional food

Company Introduction

Through 13 years of continuous research and development on ODF film technology, CLPharm developed own equipment (patent hold) and manufacturing product with it. CLPharm was also certified its ompetitiveness through many certificates like INNO-BIZ, Venture company, IP star company, technology patent, ISO 9001, ISO 14001 and KGMP. CLPharm grafted Flavor Encapsulation technology and Drug Delivery System onto original technology of edible film production that would higher drug compliance on enfant, child, elderly and infirm who have trouble in swallow pills. CLPharm owns technology that can be applied on various fields from functional food to medication and we are sole enterprise in the world with this specialized technology.

Main Products “Hemoramin”, film type iron and folic acid supplement. “Ramea”f ilm type antiemetic medication. “Ignis”, film type Erectile Dysfunction medication.

www.clpharm.com □

12 CMG PHARMA Tadalafil OTF,

Aripiprazole OTF, Entecavir OTF etc.

To be updated www.cmgpharma.co.kr □

11 DAEWON PHARM. CO., LTD. Synthetic / Herbal

Medince / DDS

Pelubiprofen Tab. (New Chemical Entity)

• Composition : Each tablet contains Pelubiprofen 30mg

• Indications : Reduce symptoms of Osteoarthritis, Rheumatoid

arthritis and Back pain.(Lumbago)

• Dosage & Administration : 1 tab.(30mg), 3 times daily after meals.

1. Pelubiprofen demonstrates outstanding efficacy for osteoarthritis and back-pain (lumbago), and rheumatoid.

2. Pelubiprofen is prodrug type which has strong analgesics and anti-inflammatory efficacy through absorbed and then transferred to active metabolties. The safety was also demonstrated through the result of clinical studies.

3. SR (Slow release) Tab. is also under development and planned to be released in 2015.

Megestrol Acetate Susp. (800mg/20mL) / ES Susp.(625mg/5mL) Megestrol Acetate is indicated for the treatmentof anorexia, cachexia,

www.daewonpharm.com □



or an unexplained, significantweight loss in patients with AIDS or cancer.

Freefol-M Inj. (1 vial, propofol 10mg/mL) MCT/LCT- drug carrier emulsion - Pain caused from injection is significantly decreased. - Optimization in Lipid metabolism. / No effect in respiratory system.

Wontran SR Tab. (Acetaminophen 650mg + Tramadol 75mg) Wontran SR Tab. is slow release formulation of Janssen Ultracet Tab Moderate to moderately severe Pain / 1~2 Tab. every 12 hours

12 DAEWOONG PHARMACEUTICAL CO., LTD.

Biosimilar , New Drug for Alzheimer

& HBV

Company Introduction Daewoong has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company by 2015. In addition, Daewoong has built strong core competency for new drug development and has cultivated a cooperative culture for collaboration with global partners. In the future, Daewoong will expand its global business with its foreign branches and partners and become a global healthcare group which contributes to improving the quality of life for people worldwide.

Main Products We are a leading manufacturer of Ursodeoxycholic acid (UDCA / Ursodiol) - Compliance with global standards : EP, USP, JP, BP, KP Meropenem

- Compliance with global standards : EP, USP, JP Lansoprazole, Rabeprazole, Cefotiam, Valsartan, etc.

www.daewoong.com □

13 DONG WHA PHARM. CO., LTD. NCE

Main Products - Clozapine Strength : 25mg , 100mg - Olanzapine Strength : 5mg , 10mg - Amlodipine / Valsartan Strength : 5mg/80mg , 5mg/160mg , 10mg/160mg - Rebamipid Strength : 100mg - Glimepiride / Metformin hydrochloride Strength : 1/250mg , 2/500mg

R&D Pipeline

- Zabofloxacin(DW224) indication : Antibiotics Status : Phase III Characteristic & Merit

• Gram (+) resistant bacteria, respiratory tract infections, particularly

pneumoniae - DW1029M indication : Diabetic nephropathy Status : Phase II Characteristic & Merit

• New herbal drug

• Microalbuminuria

• Safety & low side effect

- DW2006 indication : Allergic rhinitis Status : Phase II Characteristic & Merit

• New herbal drug

• efficacy in wide range of immune diseases

• Safety & low side effect

www.dong-wha.co.kr □

14 DONG-A ST Pharmaceutical

Company Introduction Dong-A ST focuses on ethical drugs, such as domestically developed new drugs like Stillen, Zydena, and Motilitone, medical devices, diagnosis, and overseas business. With its optimized research infrastructures such as its world-class, sophisticated research center completed in 2011, as well as its excellent researchers, Dong-A ST is furthering its efforts to develop global new drugs. Also, with the backing of these infrastructures, Dong-A ST vows to positively explore overseas markets, to expand its overseas exports, and to establish itself as a global pharmaceutical company, operating beyond the domestic market. Main Products 1.EPORON 2.GROWTROPIN 3.ZYDENA 4.CLOSERIN 5.MONOTAXEL 6.LEUCOSTIM 7.GONADOPIN 8.STILLEN 9.GEMCIT 10. CIRCULAN

www.donga-st.com □

15 DONGWOO SYNTECH. CO., LTD. API, Intermediates,

Chemical and Nutritional Products

Company Introduction DongWoo is a fast growing API synthetic company operating under WHO-GMP guidelines. DongWoo is a R&D focused company with its researches covering not only on the development of cost-effective and innovative processes but also on new substances. As result of R&D efforts, DongWoo has applied for many of crystalline and

www.dongwookr.com □



process patent and is participating in several government technology development project including Nano technology for Anti-diabetics. DongWoo Syntech has also received approval for many KDMF products by Korea FDA and has applied CEP / EDMF for several APIs in Europe market as well as JD MF for Japan market. In addition to the DMF fillings, DongWoo has received audit by independent auditor from European country with success. Also recently inspected and approved by PMDA Feb,2014. DongWoo Syntech has been certified as a“Venture company”and“INNO BIZ Company”by Korean government authorities. DongWoo is always ready to discuss contract manufacturing of API as well as intermediate business as your good partner. Main Products Rebamipide, Temocapril HCl, Butenafine HCl, Terbinafine HCl, Naftopidil, Glimepiride, Mosapride, Voglibose, Pioglitazone HCl

16 DREAM PHARMA CORP. Pharmaceutical

Company Introduction As the market leader in the antiobesity field, DreamPharma is the manufacturer of Furing (our first proprietary product approved by the KFDA), Panbesy (an effective 30mg sustainedrelease pill), and nutritional dietary supplements, such as Multivitamin Phyto and Cytrics C. Starting business in 1996 as Hanwha Co., Ltd., Pharmaceutical Business Division, DreamPharma has realized its vision of "Enhancing the Quality of Life" by developing Prescription Drugs. Main Products

• Antihistamines : Estina Tablet • Pain : Iburos Tablet • Gastrointestinal : Spasmex • Respiratory : Theoclear Cap.130mg • Circulatory : Dusoril Cap. • Dermatology : Astart Cream • Antiobesities : Arbol Cap. • Injection : Hiloneed Inj. • Others : Colonlyte Powder 2L

www.dreampharma.co.kr □

17 ENZYCHEM LIFESCIENCES CORPORATION

APIs

Company Introduction Enzychem Lifesciences Corporation is a Global New Drug Development Venture that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center located in KAIST in Daejeon and its two GMP manufacturing plants in Jecheon, it has since been developing and producing APIs and functional health foods, and developing global new drugs as the leader of the field. Enzychem Lifesciences is an innovative enterprise marketing APIs both domestically and overseas. It has developed global new drugs to treat chemotherapy-induced neutropenia, chemotherapy-induced thrombocytopenia, sepsis, cancers, and autoimmune disorders that uses EC-18 (PLAG, a substance naturally duplicated from deer antlers). It also owns dozens of intellectual properties with regard to the processes and uses of EC-18 and the processes of 1st generic pharmaceutical ingredients and produces APIs meeting EU GMP quality standards thanks to its state-of-the-art GMP facilities for synthetic process. In addition, after its first GMP plant (specializing in the production of cephalosporin), it completed its second GMP plant (specializing the manufacture of non-cephalosporin) in October 2012. It is now pushing for the production of not only cephalosporin but also non-cephalosporin and functional health products enhancing immunomodulation. Enzychem Lifesciences makes all its efforts to become a global biopharmaceutical firm that "develops global new drugs that understand and fulfill the unmet needs of patients, that develops new drugs that meet patients' indispensable yet unfulfilled medical needs, and that contribute to the health and happiness of humanity" under the towering mission and motto that "We save human lives one at a time." Business

• Global New Drug : EC-18, a blockbuster of an oncology drug

• Health Food Rockpid : Rockpid, made by PLAG, The mystery of

2000-year deer antlers naturally duplicated by modern sciences is based • APIs (Active Pharmaceutical Ingredients) : Production & Sale of APIs

www.enzychem.com □

18 Green Cross Corporation Biological Products

Company Introduction Green Cross is an exemplary R&D-oriented company that leads the biotechnology industry in Korea. Starting from the nation‟s first production and sales of Plasma Fractions in 1970, which required sophisticated technology, Green Cross has striven to develop ethical drugs that are hard to produce but essential to patients. Subsequently, it is now an internationally recognized biotechnology company in the fields of plasma fractions and vaccine. • 1974-Started manufacturing the AHF, and antihemophilic factor • 1983-Succeeded in developing the world‟s third Hepatitis B vaccine after 12 years of study • 1988-Succeeded in developing the world‟s first vaccine against the epidemic hemorrhagic fever (Hantavax) • 1989-Mogam Biotechnology Research Institute was designated by the WHO as a partner research institute • 2011-The influenza vaccine GC FLU became the fourth in the world to obtain Pre-Qualification approval from the WHO

Main Products • Human Serum Albumin

http://eng.greencross.com □



• Human Intravenous Immunoglobulin • Human hepatitis B Immunoglobulin • Human Tetanus immunoglobulin • Varicella Zoster Immunoglobulin • Human Blood Coagulation Factor vlll • Recombinant Coagylation Factor vlll • Split Virion Unactivated Influenza Vaccine • Live Alltenuated varicella Vaccine • Inacivated Japanese Encephalitis Vaccine.

19 GUJU PHARM. CO., LTD. Production and Sale of Medicines

Main Products • APITOXIN Inj. (Dried Honeybee Venom 1mg) • NEWLAXON Inj. (Ceftriaxone sodium 1g) • Disolin Inj. (MethylPrednisolone sodium succinate 40mg) • Figure-S Cab. (Green tea extract 375mg) R&D Pipeline

• Anti-obesity agenting botanical drug MINI (Code name) (Phase II

completed)

• Anti-fatty liver botanical drug (early stage) • New-liver function improved drug • New form or improved form of approved drugs

www.gujup.co.kr □

20 HANLIM PHARM. CO., LTD. Pharmaceutical

Main Products

• Naidipine tab.

API : Amlodipine Indication : Anti-hypertensive Partner : Ildong / Daewoong Clinical Study : Phase 1 Remark : New salts

• Lodien tab.

API : S-amlodipine nicotinate Indication : Anti-hypertensive Partner : Shinpoong Clinical Study : Phase 1, 3, 4 Remark : Chiral / New salts

• Risenex Plus tab.

API : Risedronate + Vit D3 Indication : Anti-oesteoporosis Partner : Daewoong / Pacific Clinical Study : Phase 3, 4 Remark : New combination (once a week)

• Risenex M tab.

API : Risedronate + Vit D3 Indication : Anti-oesteoporosis Partner : Hanmi Clinical Study : Phase 1, 3, 4 Remark : New combination (once a week)

• Nasaflex nasal spray

API : Mometasone furoate / Azelastine HCI Indication : Allergic rhinitis Partner : Hanmi Clinical Study : Phase 3, PMS Remark : New combination

www.hanlim.com □

21 HANMI PHARMACEUTICAL CO., LTD.

NCE

Finished Products (CTD completed) Amlodipine+Losartan Tab. Strength : 5/50mg, 5/100mg, 10/50mg Esomeprazole Cap. Strength : 20mg, 40mg Naproxen+Esomeprazole Tab. Strength : 500/20mg Clopidogrel Cap. Strength : 75mg Ceftriaxong Inj. Strength : 250mg, 500mg, 1g, 2g Sodium Hyaluronate Inj. Strength : 20mg in 2ml API (2 API Plants) Cephalosporin API General API -Cefotiam HCI -Montelukast -Ceftizoxime sodium -Pregabalin -Ceftazidime for Inj. -Pioglitazone -Cefixime -Irbesartan -Ceftriazone -Telmisartan -Cefotaxime -Hyaluronic acid

www.hanmipharm.com/eng/ □

22 HAPPY CALL CO., LTD. Cosmetic

Ingredients, API

Company Introduction Happy-call, established in 1997 with the spirit of faith and sincerity, has been growing up as a distributor of raw materials in cosmetics and pharmaceutical industry. We promise our customers that we will offer one-stop service on every kind of permission of import/export

Main Products 1. Raw materials of Cosmetics and pharmaceuticals

□



2. Related products

23 HUONS CO., LTD. TOTAL HEALTH

CARE

Main Products

1. EYE DROP (ETC, KYNEX 2 EYE DROPS) 2. DENTAL CARTRIDGE (ETC, LOCAL ANESTHETIC-LIDOCAINE) 3. ALLOON TAB (OTC, ANTI-OBESITY) 4. ELARVIE (MEDICAL DEVICE, SODIUM HYANULONIC ACID) 5. MERIT C ACID (DIETARY SUPPLEMENT, VITAMIN C)

R&D Pipeline 1. BOTULINUM TOXIN TYPE A (HUTOX, PRE-CLINICAL, TEMPORARY IMPROVEMENT OF GLABELLAR LINES) 2. MAGNOLIAE CORTEX EXTRACT (HU002, PHASE 2, FATTY LIVER) 3. CYCLOSPORINE 0.05% (PAHSE 3, DRY EYE SYNDROME) 4. CLOPIDOGREL 75MG + ASPIRIN 100MG (ARIGREL ACP, ARTERIOSCLEROSIS) 5. NENOMA TAB (CLOMIPRAMINE 15 MG, PREATURE EJACULATION) 6. CLOMIPRAMINE 15MG + SILDENAFIL 100MG (PHASE 1, PREMATURE EJACULATION + ERECTILE DYSFUNCTION) 7. AMLODIPINE CAMSYLATE 7.84MG + LOSARTAN POTASIUM 100MG (LOCATAN TAB, ARTERIOSCLEROSIS TREATMENT)

New Active Substances 1. MAGNOLIAE CORTEX EXTRACT (HU002, PHASE 2, FATTY LIVER) 2. CYCLOSPORINE 0.05% (PAHSE 3, DRY EYE SYNDROME)

www.huons.co.kr □

24 IL-YANG PHARMACEUTICAL CO., LTD.

Urology, GI, Dermatology

New chemical

Entity

Company Introduction Under the corporate philosophy of "Value Creation with Respect for Man's Life and Dignity", IL-YANG PHARM was established in 1946 and stepped forward with the growth of Korean pharmaceutical industry. Having founded organic raw material composition plant in 1983 and GMP plant in 1985, we modernized our production facilities and released 'Ganoderma Lucidum Youngbichun Drink', being the leader in the nutrient tonic market. Later with a great ambition, IL-YANG started to develop new material as of 1986 and invested considerable profits from Wonbi-D and Youngbichun in a search for epoch-making cures and new medicine development. Particularly, 'Ilaprazole', the next generation medicine for gastric ulcer, obtained patents in USA and Japan, enabling continued investment in research and development. For now, Chairman Chung Do-oen and CEO Kim Dong-yeon is building up adamant corporate culture through continued management innovation and carrying out aggressive investment in research and development. IL-YANG is now preparing for future with an aim to become the best global pharmaceutical company. With the start of 'No. 14 Noltec(Ilaprazole)', so-called next generation's antiulcer medicine, we are developing 'Supect', a super leukemia medicine and expanding into the field of vaccination business and BIO medication. Main Products [Finished Products] 1. Dried Aluminum Hydroxide Gel Power 2. Aluminum Hydroxide Gel 3. Aluminum Hydroxide –Magnesium Carbonate Co-dried Gel 4. Magnesium Trisilicate Power 5. Magaldrate 6. Dried Aluminum Phosphate Gel 7. Hydrotalcite

www.ilyang.co.kr □

25 IMMUNEMED INC.

Company Introduction ImmuneMed Inc. promises to become a world-trusted company based on creative high-tech intensive research and sound management. Our mission is on human health and welfare in terms of the treatment of incurable or obstinate diseases. We believe that the human immune system itself is the most effective defense system of our body in curing various infectious diseases. These beliefs have been a guiding principle for our research over the years. Using the innate immune system, a new antiviral cytokine has been developed and the research has been done using various techniques,such as virus culture, protein purification, RT-PCR,gene cloning, ELISA, MALDI-TOF protein expression in conjunction with animal experiments. In addition, we are also developing diagnostic kits using lateral flow immunochromatographic assay for early detection of acute febrile illnesses such as Scrub typhus, Lepospirosis, Hemorrhagic fever with renal syndrome, and a Murine typhus. Main Products Leptospira RAPID Scrub Typhus RAPID Hanta RAPID Murine Typhus RAPID AFI RAPID

www.immunemed.co.kr □

26 JEIL PHARMACEUTICAL CO., LTD.

Pharmaceutical

1. Kefentec Plasta 3. Yamatetan 5. Omnicef 7. Lanston 9. Gastrex

2. Stablon 4. BUP-4 6. Berasil 8. Cravit

10. Inhibace

www.jeilpharm.co.kr □

27 JW PHARMACEUTICAL CORPORATION

Anti Cancer, Formulation

research

Company Introduction Since its foundation, JW Group has led the hospital market based on respect for life and the pioneering spirit, and is now being reborn as a global healthcare company to lead the industry into the 21

st

century. Based on leading competitiveness in the ethical drug market, JW Pharmaceutical has built up strong sales network across

www.jw-pharma.co.kr □



the country and superior pipelines in I.V solutions, antibiotic, cardiovascular, gastrointestinal, nephrology, anticancer and neuropsychiatry. And now, it is pioneering the rapidly growing new field such as diabetes and so on. It has been striving to produce and provide innovative new technologies and services heading for healthy lives of human beings on the basis of its founding spirit of “Respect for life”. Main Products • Carbenem Antibiotics • Antifungal Agents • Anticancer drugs • I.V Solutions • Other antibiotics

28 KGCYEBON

Natural API CMO / Health Functional

Food Raw Material OEM, ODM

To be updated www.kgcyb.co.kr □

29 KM CORP.

Main Products • Perpak We consult and support you to properly apply sterile packaging

materials and a total of 3,000 kinds of products for a clean room to various certifications(KGMP&etc.) at Bio/ Pharmaceuticel industry. • CleanQplus (www.cleanqplus.com) CleanQplus is on-line shopping mall to provide cleanroom and safety supplies for companies and laboratories. We have supplied more than 3,000 kinds of products with the reasonable quality and price to enhance the value of the customer. • Savillex products / Gore Sealants / Wada Savillex products are used in laboratories involved in analyses of all types in every step from gathering the sample to analyzing the sample. Gore Sealants are among the world‟s tightest chemically-resistant gaskets. Wada have supplied the clean pressurized canisters to the needs of Fine chemical, Pharmaceutical, Food/Beverage industry

http://kmbiz.com □

30 KOREA UNITED PHARM. INC.

NME, IMD, Generic drugs & Other

Healthcare Products

Main Products • Clanza CR tabs. World Only One, Once Daily aceclofenac Best in NSAIDs in terms of Safety & Effectiveness Launched in Korea, Vietnam, Philipine On registering in Russia, Kazakhstan, Ukraine, Venezuela, China • Clavixin Duo caps. Combined Product of Clopidogrel and Aspirin Filled with Clopidogrel granules(IR) and Aspirin Less undesirable effects Launched in Korea • Cilostan CR tabs. The World One and Only Cilostazol CR 200mg Less side effects of headache & tachycardia Improved patients' compliance - One tablet Once daily Launched in Korea On registering in China

www.kup.co.kr □

31 LG LIFE SCIENCES LTD.

Company Introduction LG Life Sciences began research in genetic engineering in 1981 and has invested steadily in the life sciences ever since. This effort has already resulted in world-class technology and product capabilities. The company has focused R&D resources and know-how on three areas-pharmaceuticals, animal health and specialty chemicals. LG Life Sciences has developed and commercialized an array of pharmaceuticals over the years. These include interferon in 1989 (Intermax-gamma) and 1992 (Intermax-alpha), hepatitis B vaccine in 1992 (EUVAX B™), human growth hormone in 1993 (EUTROPIN™), degenerative arthritis treatment in 2005 (HYRUAN Plus™), rhFSH (recombinant human follicle stimulating hormone) in 2006 (Follitrope™), and SR-hGH (Sustained Release-human Growth Hormone) in 2007 (Declage™). A company milestone was reached in 2003, when its next-generation quinolone antibiotic (FACTIVE®) was approved by the FDA in the United States. LG Life Sciences has succeeded in animal health products including the 1994 commercialization of recombinant bovine somatotropin (BST, product name BOOSTIN®). The product, which is used to increase milk production in lactating dairy cows, has achieved the top share in numerous national markets. In 2006, LG Life Sciences has also launched a bovine mastitis vaccine (MastaVac) that reduces the number of somatic cells, relieving clinical symptoms in a cow that has been infected with mastitis. As for specialty chemicals, LG Life Sciences completed in-house development of Korea's first new herbicide (PYANCOR®) for rice in 1997 and fungicide (GUARDIAN®) for use in horticulture in 1999. A new herbicide (FLUXO®) for both pre- and post-emergence rice was completed in 2004.

www.lgls.co.kr □

32 LSK GLOBAL PHARMA SERVICES

CRO SERVICE Company Introduction LSK Global Pharma Service is the highest quality contract research organization (CRO) that can be sought out. Founded in March of

www.lskglobal.com □



2000, LSK Global PS has since been making an extensive effort to provide clinical trial services that meet global standards. We perform clinical trials based on SOPs (drafted in English) which strictly follow ICH-GCP guidelines in order to improve clinical trial quality, and we are using a system to meet international standards.

Scope of Service

• General Consulting

- Regulatory Strategy Consulting - Bridging Study Strategy - Study Design Consulting - Product Development Consulting

• Monitoring

- Monitoring (SIV, IMV, COV, Query Resolution etc.) - Documentation (Collection and Maintenance of TMF / ISF / PF) - Safety Management - Site Management

• Medical Writing & Research

- Protocol Development (Korean, English) - CSR Development (Korean, English)

• DM/STAT/CSR

- Data Management (DM) (EDC & paper-based) - Statistical Services - Clinical Study Report (CSR) (Korean, English) - CRF Development (Paper & e-Contents)

• RA/SSU

- Regulatory Affairs (IND) - Feasibility (Site / Investigator Selection) - PSSV (Pre-Study Site Visit) : Site Qualification Visit - IRB Submission - CTA (Clinical Trial Agreement) - IP / non IP Import - GSP (Good Supply Practice) Service

• PMS/Observational Studies

- Post Marketing Surveillance (PMS) - Observational / Epidemiological Studies

• Drug Registration Service

- Registration Strategy - NDA Package Preparation / Submission - Reimbursement Package / Submission

33 MH2 BIOCHEMICAL CO., LTD.

BIOCATALYSIS (FOOD ADDITIVE, HEALTH FOOD, COSMETICS)

Company Introduction During last 10 years we have supplied some amino acids such as Ornithine, Citrulline and GABA through fermentation and enzymatic processes as ingredients of food and dietary supplements, meanwhile we have worked to secure the sustainable processes of unnatural amino acids and chiral intermediates by using ω-transaminase, lipase and etc. We are pleased to introduce these new products to the customers Main Products • Ingredients : L-Ornithine, L-Citrulline, GABA, L-Serine, D-Alanine, D-Glutamic acid, D-Aspartic acid, D-Arginine • Anti-hangover (finished good): CHUISUN, CHOSUN • Beauty food (Finished good): Beauty Carotene

www.mh2.co.kr □

34 NBM INC.

Cosmetic Ingredients,

Recombinant Proteins(Medical

Materials), Functional Materials

Company Introduction NBM Inc. is an innovative company for the production of recombinant proteins such as growth factors, antibodies, cytokines, and proteases by using plant. The company is also advancing to produce recombinant biopharmaceutical proteins development programs. NBM Inc. is expanding to cosmetics and pharmaceutical industry in the global market with its progressive products and is highly acclaimed at home and abroad because of its technology competitiveness. Our product portfolio has expanded steadily to meet the needs of our customers with biorisk-free growth factors and cytokines. Main Products NBM Inc. has produced a range of high-grade, animal-free and endotoxin-free growth factors produced from rice cell culture, which have recently been recognized as the next generation‟s new materials for cosmetics. The high quality Growth factors & Cytokines of NBM Inc. satisfy cosmetic manufacturers and end customer with high safety and efficacy. NBM Inc. is instead committed to produce high quality recombinant proteins for cosmetic ingredients which will provide benefits directly to the consumer by using plants as bio-reactors. NBM Inc. can produce from milligrams to kilograms of the high quality recombinant protein to satisfy our client‟s needs. • Rice Cell-produced Cosmetic Ingredients - hEGF, hFGFa, hFGFb, hVEGF-165, hKGF, hGM-CSF High purity grade | Animal Free | Mouse Free | Bacteria Free | Endotoxin Free

www.nbms.co.kr □



35 SAMCHUN PURE CHEMICAL

Company Introduction

SAMCHUN GROUP consists of big three axes, Samchun Chemical Co., Samchun Pure Chemical Co. and Samchun Development Co. These axes are connected with the networks of four branch offices organically, establishing an integrated system to tackle and resolve any pending issue cooperatively. This cooperative system creates many advantages: cost reduction, high efficiency, high productivity and smooth performance of jobs assigned. Samchun Chemical is focused on sales, international business, planning, corporate management, while Samchun Pure Chemical undertakes manufacturing and logistics. Each branch office deals with sub-dealers and specific customers for reagent chemicals, laboratory equipment and supplies. Main Products We have broadened the product range of SAMCHUN brand upto over 1,500 items and keep in stock various foreign brands of over 19,000 items, which are available from our stocks any time. We have also set up an efficient, well-organized logistics systems and 24-hour delivery system, an optimal delivery networks of many branch offices to better serve customers‟ various needs. You can

get satisfactory solutions from Samchun with one phone call if you have any question or requirement for your R&D projects. In addition to the products covered by our catalog, we offer custom-manufacturing/synthesis services. You are welcome to contact, visit us any time.

• Reagent Chemicals

- General reagents - Specialty reagents - Various imported reagents

• Equipment & Instruments

- ADVANTEC - Whatman - Products of other Japanese makers

• Synthesis Raw Materials

- About 300 manufactured items (custom-manufacturing offered)

• Pharmaceutical Raw Materials

- About 150 regular items including over 30 times of surfactents, food additives, cosmetic raw matericals (skin moisturizer), fragrance designs

www.samchun.com □

36 SHIN POONG PHARM. CO., LTD.

Rheumatoid arthritis and osteoporosis, Blood circulation

system, Infectious disease

Main Products 1. Pyramax film-coated tablet 180mg/60mg 1) API : pyronaridine tetraphosphate / Artesunate 2) Indications : the treatment of acute, uncomplicated malaria infection caused by Plasmodium falciparum or by Plasmodium vivax. 2. Loxfen CR tablet 90mg 1) API : Loxoprofen sodium 2) Indications : Chronic rheumatoid arthritis, osteoarthritis, lumbago, scapular periarthritis, neck-scaplular syndrome, analgesic and anti-inflammation of post-operation, post-trauma and post-arrachement. R&D Pipeline [NCE] SP-8203 : Stroke (Phase I) SP-35454 : Osteoporosis (Preclinical) JSH-2236 : Heart failure (Preclinical) [IMD] AC-001 : Hypertension (Phase II) ER-001 : Hyperlipidemia (Phase I)

www.shinpoong.co.kr □

37 SK CHEMICALS CO., LTD.

NCE, Herbal medicine, Vaccine,

IMD, Biologics, Plasma products

Company Introduction SK Chemical is a member company of SK Group, the third largest company group in Korea. Since founded in 1969, SK Chemicals has focused on the development of drug products targeting the diseases with unmet treatment needs in order to fulfill its vision ; “Healthcare and Earthcare”. The R&D area of SK Chemicals covers a broad range of product lines, including new chemical entities, new herbal extract drugs, reformulated generics, vaccines and blood products. Owing to its continuous efforts on R&D, SK Chemicals was able to develop three new chemical entities(NCEs), novel drug delivery system(DDS) flat form technologies, recombinant DNA technology and in-house premium vaccines. On the basis of this strong R&D capability together with its outstanding marketing operations, SK Chemicals was selected as a member of the Korea Innovative Pharmaceutical Company. Main Products

• Sunpla® Injection • Mvix® S ODF, Mvix® Tablet • Joins® Tablet • Influenza Vaccine • TRAST® patch R&D Pipeline • NCE : Fibrosis, Diabetes • Vaccine : Influenza, PCV, Varicella • Biologics : Recombinant factor VIII

www.skchemicals.com □



• Plasma products : Immunoglobulin injection(Hepatitis B) New Active Substances • Heptaplatin(third-generation platinum anti-cancer drug) : the Korean‟s first new drug • Mirodenafil(erectile dysfunction treatment) : the worlds‟ highest score in the International Index of Erectile Function (IIEF)

38 ULSAN TECHNOPARK

Introduction The “ fine chemical industry ” is drastically rising as the next generation´;s industry that comes with high added value. To solve the weaknesses and problems in the chemical industry of Ulsan , and to be a Mecca of the Korean chemical industry in the next generation, the Fine Chemical and Material Technical Institute is preparing its ambitious plans.

www.camti.or.kr □

39 WELL E&C CO., LTD. Glass Reactor,

TCU(Temperature Control Unit)

Business Area • Consulting - Conceptual Design - GMP Consulting • Engineering - Pilot Plant - Basic / Detail Engineering - Turnkey • APIs - Raw Material - Intermediate - R&D Center

www.wellcorp.co.kr □

44 YUHAN CORPORATION

Gastrointestinal disease,

Cardiovascular disease,

Metabolic disease

Company Introduction Founded in 1926 with the mission of supporting South Korea by enhancing the quality of life for all people, Yuhan has been providing high quality medicines for the last 85 years as one of the leading pharmaceutical companies in South Korea. Since its foundation, Yuhan has set the foremost priority to provide the best medicines by building its R&D. In 2005, Yuhan moved its central research to Giheung, Gyeonggi-do, and opened the largest R&D center in the South Korea pharmaceutical industry. With state-of-the-art facilities, Yuhan is committed to deliver advanced and innovative medicines to enhance quality of life. Yuhan is focusing its R&D capabilities on developing new chemical entities, herbal medicines, market-oriented IMDs(Incrementally modified drugs), and APIs/intermediates for overseas markets. Main Products • Piperacillin Monohydrate • CMO-HIV New Drug • Ribavirin • CMO-HCV New Drug. • PEG-NHS • CMO-HIV New Drug • CMO- HIV New Drug • Cilostazol • PEG-Thiol • Levofloxacin

www.yuhan.co.kr □

45 YUYU PHARMA INC.

Company Introduction YuYu Pharma, Inc. was founded in 1941. Through the development and distribution of new drugs, medicines, and health services that aim to improve peoples‟ health and quality of life, YuYu is growing into a company with a history of “70 years of success” We have developed a number of high-grade prescription medicines such as Tanamin (medicine for dementia and peripheral circulatory disturbance), Maxmarvil (new medicine for osteoporosis treatment), CLID (thromboembolectomy treatment), and Umckamin (medicine for asthma and respiratory infection). We market each of these products through scientific marketing to maximize coverage and efficiency. Maxmarvil, the nation‟s tenth new medicine and the first combined new medicine, is taken to treat osteoporosis and is widely favored by patients and doctors due to its high efficacy and safety. YuYu also has the distinction of having developed the nation‟s second combined new medicine, YUCILD, a cure for stroke. For general medicines, we have Yupan-C (Vitamin C), Venapollo (multivitamin for nearly 50 years), Venoplus Gel (bruise ointment), Physiomer (nasal cavity washer), and Noiromin (plant antidepressant), which are available at any pharmacy. Main Products • Prescription

www.yuyu.co.kr □



- Osteoporosis Drugs - BrainBone Metabolism-Hypocalcemia Improvement Drug - Cerebral & Peripheral Circulatory Disturbance Drug - Tromboembolism Drugs - Respiratory Organ Drugs - Hypertension Drugs - Other Circulatory System Drugs - Hyperlipidemia Drugs - Antibiotics - Pulmonary Tuberculosis Therapy Drug - Migraine Drugs - Arthrifuge - Antipyretic Analgesic and Anti-Inflammatory Agent - Diabetic Neuropathy Therapy Drug - Skeletal Muscle Relaxant - Antihistamine - Urinary System (Organ) Drugs - Eczematous Dermatitis Drugs • Non-Prescription - Physiomer Baby Nasal Cavity Cleaning Solution

- Physiomer Kids Nasal Cavity Cleaning Solution - Physiomer Gentle Nasal Cavity Cleaning Solution - Physiomer Strong Nasal Cavity Cleaning Solution - Physiomer Pump Mist Nasal Cavity Cleaning Solution - VENOPLUS Gel - TANAMINE Tablet - NOIROMIN Tablet - Venapollo-Extra Soft Capsule - YUTRI Gel - Barosofen Soft Capsule - YU-Achuoo Capsule - Sokpyunase Tablet - Relax Tablet - Tanasol Solution - Yupan-C 1000 Plus Tablet - Tuguard Soft Capsule

• Quai Drugs - Yupan-C Tablet - Yupan-C Pop

- BB White Premium Tablet • Health Supplement - Formoline - Hi-Q

- Lycopene - YuYu Caldi - EyeYou Lutein Zeaxanthin - BB White Collagen - Miffy Vita 1000T

Documents

KOREA PHARM 2015 hostED BUYER Programk-jit.com/.../KOREA-PHARM-2015_Exhibitor-List_20150224.pdfresearch and development and made continuous efforts to produce high-quality products